Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Caffeine Citrate
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India | Gates Foundation | University of Virginia | University of Alabama at Birmingham | Thomas Jefferson University | Columbia University | University of Colorado,
Deal Size : Inapplicable
Deal Type : Inapplicable
Caffeine for Hypoxic Ischemic Encephalopathy
Details : Caffeine Citrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypoxia-Ischemia, Brain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 03, 2025
Lead Product(s) : Caffeine Citrate
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India | Gates Foundation | University of Virginia | University of Alabama at Birmingham | Thomas Jefferson University | Columbia University | University of Colorado,
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Caffeine Citrate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants
Details : Caffeine Citrate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Bronchiolitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 16, 2011
Lead Product(s) : Caffeine Citrate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable